The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Increased Doses of Oral Semaglutide Can Induce Pronounced Weight Loss, Improve Glycemic Control
June 26th 2023Data from a pair of trials presented at ADA 2023 suggests an upped dose of oral semaglutide could soon be on the horizon, with results supporting use in chronic weight management as well as type 2 diabetes.
Diabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes
June 25th 2023Often overlooked and unrecognized, the mental health challenges accompanying type 1 diabetes are becoming a focal point of discussion for many in the field, including Mark Heyman, PhD, who joined Diana Isaacs, PharmD, and Natalie Bellini, DNP, for a special ADA 2023 edition of Diabetes Dialogue.
Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD
June 25th 2023At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to address shortfalls of the current language used in the management of diabetes.
ADA Updates Standards of Care to Include Teplizumab for Delaying T1D, Reflect Emphasis on NAFLD
June 25th 2023At their annual meeting, the American Diabetes Association debuted updates to their Standards of Care to reflect the approval of teplizumab for delaying the onset of type 1 diabetes and underline the importance of screening for NAFLD in type 2 diabetes.
Study Suggests Bempedoic Acid Could Find Role in Primary Prevention
June 24th 2023An analysis of a primary prevention subgroup within the CLEAR Outcomes trial presented at ADA 2023 suggests use of bempedoic acid was associated with a 30% relative risk reduction for MACE among this patient population.
Phase 1/2 Data Show Potential of VX-880 for Insulin Independence in T1D
June 24th 2023New results from the ongoing clinical trial of VX-880 suggested all patients with T1D treated with the novel stem cell-derived islet cell therapy showed restored endogenous insulin secretion and improved glycemic control.